Objects
D'Amico, Anthony V., Chen, Ming-Hui, Crook, Juanita, Armstrong, John G., Malone, Shawn, Steigler, Allison, Dunne, Mary, Kantoff, Phillip W., Denham, James W.. American Society of Clinical Oncology; 2011. Duration of short-course androgen suppression therapy and the risk of death as a result of prostate cancer.
D'Amico, Anthony V., Chen, Ming-Hui, de Castro, Mario, Loffredo, Marian, Lamb, David S., Steigler, Allison, Kantoff, Philip W., Denham, James W.. Lancet Publishing Group; 2012. Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials.
Warren, Laura E. G., Chen, Ming-Hui, Denham, James W., Steigler, Allison B., Renshaw, Andrew A., Loffredo, Marian, Kantoff, Philip W., D'Amico, Anthony V.. Springer; 2016. Gleason score and the risk of cause-specific and all-cause mortality following radiation with or without 6 months of androgen deprivation therapy for men with unfavorable-risk prostate cancer.